Abstract
Cisplatin (cis-diamminedichloroplatinum(II)) is widely used in the treatment of testicular and ovarian cancers. A number of biological and biochemical results indicate that the reaction of cisplatin with DNA is responsible for the cytotoxic action of this drug. The effect of platinum compounds on the conformation and stability of DNA has been investigated and several platinum-DNA adducts have been identified in vitro and in vivo. Preliminary experiments have quantified the effect of these different lesions on DNA replication, their capacity to induce mutations and their susceptibility to DNA repair processes. Additional DNA damage may be created by platinum(IV) compounds, perhaps during their reduction to platinum(II) compounds by the cell.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Prestayko AR, Crooke ST, Carter SK (eds) (1980) Cisplatin current status and new developments. Academic, New York
Harrap KR (1985) Cancer Treat. Revs. 12: 21
Roberts JJ, Thomson AJ (1979) Prog. Nucl. Acid Res. Mol. Biol. 22: 71
Macquet JP, Butour JL, Johnson NP (1983) in: S. J. Lippard (ed) Platinum, gold and other metal chemotherapeutic agents: chemistry and biochemistry. American Chemical Society, Washington, p 75
Pinto AL, Lippard SJ (1985) Biochim. Biophys. Acta 780: 167
Johnson NP, Lapetoule P, Razaka H, Villani G (1986) In: McBrien DCH, Slater TF (eds) Biochemical mechanisms of platinum antitumour drugs. IRL, Oxford, p 1
Reedijk J, Fichtinger-Schepman AM J, van Oosterom AT, van de Putte P (1987) Structure and Bonding 67: 53
Eastman A (1987) Pharmae. Ther. 34: 155
Roberts JJ, Friedlos F (1987) Pharmae. Ther. 34: 215
Sherman SE, Lippard SJ (1987) Chem. Rev. 87: 1153
Lippert B (1988) Gaz. Chim. Ital. 118: 153
Manaka RC, Wolf W (1978) Chem.-Biol. Interact. 22: 353
McBrien DCH, Slater TF (eds) (1986) Biochemical mechanisms of platinum antitumor drugs. IRL, Oxford
Pascoe JM, Roberts JJ (1974) Biochem. Pharmacol. 23: 1345
Monti-Bragadin C, Tamaro M, Banfi E (1975) Chem.-Biol. Interact. 11: 469
Lecointe P, Macquet JP, Butour JL, Paoletti C (1977) Mutation Res. 48: 139
Johnson NP, Hoeschele JD, Rahn RO, O’Neill JP, Hsie AW (1980) Cancer Res. 40: 1463
Plooy ACM, van Dijk M, Lohman HM (1984) Cancer Res. 44: 2043
van den Berg HW, Roberts JJ (1975) Mutation Res. 33: 279
Bonatti S, Lohman PHM, Berends F (1983) Mutation Res. 116: 149
Brodberg RK, Lyman RF, Woodruff RC (1983) Environ. Mutagen. 5: 285
Tandon P, Sodhi A (1985) Mutation Res. 156: 187
Shooter KV, Howse R, Merrifield RK, Robins AB (1972) Chem.-Biol. Interact. 5: 289
Munchausen LL (1974) Proc. Natl. Acad. Sci. USA 71: 4519
Villani G, Lherisson C, Defais M, Johnson NP (1987) Mutation Res. 183: 21
Knox RJ, Lydall DA, Friedlos F, Basham C, Roberts JJ (1987) Biochim. Biophys. Acta 908: 214
Rosenberg B, van Camp L, Grimley EB, Thomson AJ (1967) J. Biol. Chem. 242: 1347
Reslova S (1971/72) Chem.-Biol. Interact. 4: 66
Lecointe P, Macquet JP, Butour JL (1979) Biochem. Biophys. Res. Comm. 90: 209
Walker GC (1984) Microbiol. Rev. 48: 60
Painter RB (1977) Nature 265: 650
Howie JA, Gale GR (1970) Biochem. Pharmacol. 19: 2757
Harder HC, Rosenberg B (1970) Int. J. Cancer 6: 207
Beck DJ, Brubaker RR (1973) J. Bact. 116: 1247
Drobnik J, Urbankova M, Krekulova A (1973) Mutation Res. 17: 13
Fraval HNA, Rawlings CJ, Roberts JJ (1978) Mutation Res. 51: 121
Roberts JJ, Fraval HNA (1978) Bioehimie 60: 869
Cleare MJ (1974) Coord. Chem. Rev. 12: 349
Alazard R, Germanier M, Johnson NP (1982) Mutation Res. 93: 327
Plooy ACM, Lohman PHM (1980) Toxicology 17: 169
Salles B, Lesca C (1982) Biochem. Biophys. Res. Comm. 105: 202
Johnson NP, Hoeschele JD, Kuemmerle NB, Masker WE, Rahn RO (1978) Chem.-Biol. Interact. 23: 267
Beck DJ, Brubaker RR (1975) Mutation Res. 27: 181
Beck DJ, Fisch JE (1980) Mutation Res. 77: 45
Caskey CT, Kruh GD (1979) Cell 16: 1
Skipper HE, Schabel FM, Wilcox WS (1964) Cancer Chemother. Rep. 35: 1
Wright M, Lacorre-Arescaldino I, Macquet JP, Daffe M (1984) Cancer Res. 44: 111
Hartley FR (1973) The chemistry of platinum and palladium. Applied Science, London.
Vrana O, Brabec V (1986) Int. J. Radiat. Biol. 50: 995
Zwelling LA, Filipski J, Kohn KW (1979) Cancer Res. 39: 4989
Bradley MO, Patterson S, Zwelling LA (1982) Mutation Res. 96: 67
Zwelling LA (1983) In: S. J. Lippard (ed) Platinum, gold and other metal chemotherapeutic agents: chemistry and biochemistry. American Chemical Society, Washington, p 27
Eastman A (1986) Biochem. 25: 3912
Reishus JW, Martin DS Jr. (1961) J. Am. Chem. Soc. 83: 2457
Lim MC, Martin RB (1976) J. Inorg. Nucl. Chem. 38: 1911
Perumareddi JR, Adamson AW (1968) J. Phys. Chem. 72: 414
Jensen KA (1939) Z. Anorg. Allg. Chem. 242: 87
Rosenberg B (1978) Biochimie 60: 859
Faggiani R, Lippert B, Lock CJL, Rosenberg B (1978) Inorg. Chem. 17: 1941
Johnson NP, Hoeschele JD, Rahn RO (1980) Chem.-Biol. Interact. 30: 151
Horacek P, Drobnik J (1971) Biochim. Biophys. Acta 254: 341
Green M (1987) Transition Met. Chem. 12: 186
Butour JL, Macquet JP (1977) Eur. J. Biochem. 78: 455
Macquet JP, Butour JL (1978) Eur. J. Biochem. 83: 375
Macquet JP, Butour JL (1978) Biochimie 60: 901
Butour JL, Macquet JP (1981) Biochim. Biophys. Acta 653: 305
Pascoe JM, Roberts JJ (1974) Biochem. Pharmacol. 23: 1359
Zwelling LA, Anderson T, Kohn KW (1979) Cancer Res. 39: 365
Roberts JJ, Friedlos F (1982) Chem.-Biol. Interact. 39: 181
Schaller W, Holler E (1988) in: Nicolini, M. (ed) Platinum and other metal coordination compounds in cancer chemotherapy. Martinus Nijhoff, Boston, p 132
Kleinwachter V, Vrana O, Brabec V, Johnson NP (1988) Studia Biophys. 123: 85
Wing RM, Pjura P, Drew HR, Dickerson RE (1984) EMBO J. 3: 1201
Fichtinger-Schepman AMJ, van der Veer JL, Lohman PHM, Reedijk J (1984) J. Inorg. Biochem. 21: 103
Johnson NP, Mazard AM, Escalier J, Macquet JP (1985) J. Am. Chem. Soc. 107: 6376
Butour JL, Johnson NP (1986) Biochem. 25: 4534
Fichtinger-Schepman AMJ, van der Veer JL, den Hartog JHJ, Lohman PHM, Reedijk J (1985) Biochem. 24: 707
Marcelis ATM, Canters GW, Reedijk J (1981) Recueil J. Royal Neth. Chem. Soc. 100: 391
den Hartog JHJ, Altona C, Chottard JC, Girault JP, Lallemand JY, de Leeuw FAAM, Marcelis ATM, Reedijk J (1982) Nucl. Acids Res. 10: 4715
Girault JP, Chottard G, Lallemand JY, Chottard JC (1982) Biochem. 21: 1352
Girault JP, Chottard JC, Guittet ER, Lallemand JY, Huynh-Dinh T, Igolen J (1982) Biochem. Biophys. Res. Comm. 109: 1157
Caradonna JP, Lippard SJ (1982) J. Amer. Chem. Soc. 104: 5793
Reedijk J, Fichtinger-Schepman AMJ, den Hartog JHJ (1983) Inorg. Chim. Acta 79: 252
den Hartog JHJ, Altona C, van Boom JH, van der Marel GA, Haasnoot CAG, Reedijk J (1984) J. Amer. Chem. Soc. 104: 1528
Neumann JM, Tran-Dinh S, Girault JP, Chottard JC, Huynh-Dinh T, Igolen J (1984) Eur. J. Biochem. 141: 465
van Hemelryck B, Guittet E, Chottard G, Girault JP, Huynh-Dinh T, Lallemand JY, Igolen J, Chottard JC (1984) J. Amer. Chem. Soc. 106: 3037
den Hartog JHJ, Altona C, van Boom JH, Reedijk J (1984) FEBS Let. 176: 393
den Hartog JHJ, Altona C, van der Marel GA, Reedijk J (1985) Eur. J. Biochem. 147: 371
Sherman SE, Gibson D, Wang AHJ, Lippard SJ (1985) Science 230: 412
Admiraal G, van der Veer JL, de Graaff RAG, den Hartog JHJ, Reedijk J (1987) J. Amer. Chem. Soc. 109: 592
van Hemelryck B, Guittet E, Chottard G, Girault JP, Herman F, Huynh-Dinh T, Lallemand JY, Igolen J, Chottard JC (1986) Biochem. Biophys. Res. Comm. 138: 758
Rice JA, Crothers DM, Pinto AL, Lippard SJ (1988) Proc. Natl. Acad. Sci. USA 85: 4158
van Hemelryck B, Girault JP, Chottard G, Valadon P, Laoui A, Chottard JC (1987) Inorg. Chem. 26: 787
Laoui A, Kozelka J, Chottard JC (1988) J. Amer. Chem. Soc. 27: 2751
Dewan JC (1984) J. Amer. Chem. Soc. 106: 7239
Eastman A (1985) Biochem. 24: 5027
van der Veer JL, van den Elst H, den Hartog JHJ, Fichtinger-Schepman AMJ, Reedijk J (1986) Inorg. Chem. 25: 4657
Marcelis ATM, den Hartog JHJ, Reedijk J (1982) J. Am. Chem. Soc. 104: 2664
Marcelis ATM, den Hartog JHJ, van der Marel GA, Wille G, Reedijk J (1983) Eur. J. Biochem. 135: 343
den Hartog JHJ, Altona C, van Boom JH, Marcelis ATM, van der Marel GA, Rinkel LJ, Wille-Hazeleger G, Reedijk J (1983) Eur. J. Biochem. 134: 485
Inagaki K, Kidani Y (1984) Inorg. Chim. Acta 92: L9
den Hartog JHJ, Altona C, van den Elst H, van der Marel GA, Reedijk J (1985) Inorg. Chem. 24: 986
Plooy ACM, Fichtinger-Schepman AMJ, Schutte HH, van Dijk M, Lohman PHM (1985) Carcinogenesis 6: 561
Eastman A, Barry MA (1987) Biochem. 26: 3303
Eastman A, Jennerwein MM, Nagel DL (1988) Chem.-Biol. Interact. 67: 71
Lippard SJ, Hoeschele JD (1979) Proc. Natl. Acad. Sci. USA 76: 6091
Johnson NP, Macquet JP, Wiebers JL, Monsarrat B (1982) Nucl. Acids Res. 10: 5255
Sober H (ed) (1970) Handbook of Biochemistry, 2nd ed. The Chemical Rubber Co., Cleveland.
Theophanides T, Ganguli PK, Bertrand MJ (1981) Anticancer Res. 1: 383
Chu GYH, Mansy S, Duncan RE, Tobias S (1978) J. Am. Chem. Soc. 100: 593
Lawley PD, Brookes P (1963) Biochem. J. 89: 127
Zoltewicz JA, Clark FD, Sharpless TW, Grahe G (1970) J. Am. Chem. Soc. 92: 1741
Harder HC, Smith RG, Leroy AF (1976) Cancer Res. 36: 3821
Pinto AL, Lippard SJ (1985) Proc. Natl. Acad. Sck USA 82: 4616
Villani G, Hubscher U, Butour JL (1988) Nucl. Acids Res. 16: 4407
Bernges F, Holler E (1988) Biochem. 27: 6398
Livneh Z (1986) J. Biol. Chem. 261: 9526
Sancar A, Rupp WD (1983) Cell 33: 249
Beck DJ, Popoff S, Sancar A, Rupp WD (1985) Nucl. Acids Res. 13: 7395
Page JD, Husain I, Chaney SG, Sancar A. (1988) In: Nicolini, M. (ed) Platinum and other metal coordination compounds in cancer chemotherapy. Martinus Nijhoff, Boston, p 115
Popoff SC, Beck DJ, Rupp WD (1987) Mutation Res. 183: 129
Fram RJ, Cusick PS, Wilson JM, Marinus MG (1985) Mol. Pharmacol. 28: 51
Pera MF, Rawlings CJ, Roberts JJ (1981) Chem.-Biol. Interact. 37: 245
Bedford P, Fichtinger-Schepman AMJ, Shellard SA, Walker MC, Masters JRW, Hill BT (1988) Cancer Res. 48: 3019
Eastman A, Schulte N (1988) Biochem. 27: 4730
Ciccarelli RB, Solomon MJ, Varshavsky A, Lippard SJ (1985) Biochem. 24: 7533
Roberts JJ, Friedlos F (1987) Cancer Res. 47: 31
Brouwer L, van de Putte P, Fichtinger-Schepman AMJ, Reedijk J (1981) Proc. Natl. Acad. Sci. USA 78: 7010
Burnouf D, Daune M, Fuchs RPP (1987) Proc. Natl. Acad. Sci. USA 84: 3758
Venturini S, Monti-Bragadin C (1978) Mutation Res. 50: 1
Konishi H, Usui T, Sawada H, Uchino H, Kidani Y (1981) Gann 72: 627
Jarosik GP, Beck DJ (1984) Chem.-Biol. Interact. 51: 247
Fram RJ, Cusick PS, Marinus MG (1986) Mutation Res. 173: 13
Johnson NP, Razaka H, Wimmer F, Defais M, Villani G (1987) Inorg. Chim. Acta 137: 25
Brouwer J, Vollebregt L, van de Putte P (1988) Nucl. Acids Res. 16: 7703
Mason WR (1972) Coord. Chem. Rev. 7: 241
Rosenberg B, van Camp L (1970) Cancer Res. 30: 1799
Braddock PD, Connors TA, Jones M, Khokhar AR, Melzack DH, Tobe ML (1975) Chem.- Biol. Interact. 11: 145
Beaumont KP, McAuliffe CA, Cleare MJ (1976) Chem.-Biol. Interact. 14: 179
Tobe ML, Khokhar AR (1977) J. Clin. Hematol. Oncol. 7: 114
Rose WC, Schurig JE, Huftalen JB, Bradner WT (1982) Cancer Treat. Rep. 66: 135
Rotondo E, Fimiani V, Cavallaro A, Ainis T (1983) Tumori 69: 31
Macquet JP, Butour JL (1983) J. Natl. Cancer Inst. 70: 899
Brandon RJ, Dabrowiak JC (1984) J. Med. Chem. 27: 861
Blatter EE, Vollano JF, Krishnan BS, Dabrowiak JC (1984) Biochem. 23: 4817
Vollano JF, Al-Baker S, Dabrowiak JC, Schurig JE (1987) J. Med. Chem. 30: 716
Bramwell VHC, Crowther D, O’Malley S, Swindell R, Johnson R, Cooper EH, Thatcher N, Howell A (1985) Cancer Treat. Rep. 69: 409
Pendyala L, Cowens JW, Chheda GB, Dutta SP, Creaven P (1988) Cancer Res. 48: 3533
Rahman A, Roh JK, Wolpert-DeFilippes MK, Goldin A, Venditti JM, Woolley PV (1988) Cancer Res. 48: 1745
Leonard BJ, Eccleston E, Jones D, Todd P, Walpole A (1971) Nature 234: 43
Berenbaum MC (1971) Br. J. Cancer 261: 208
Mattern IE, Cocchiarella L, van Kralingen CG, Lohman PHM (1982) Mutation Res. 95: 79
Poll EHA, Arwert H, Joenje H, Eriksson AW (1982) Human Genet. 61: 228
Vrana O, Brabec V, Kleinwachter V (1986) Anti-Cancer Drug Design 1: 95
van der Veer JL, Peters AR, Reedijk J (1986) J. Inorg. Biochem. 26: 137
van der Veer JL, Ligtvoet GJ, Reedijk J (1987) J. Inorg. Biochem. 29: 217
Astashkina TG, Vlasov W, Kazakov SA, Cvetkov IV (1988) Dokl. Akad. Nauk. SSSR 301: 234
Brabec V, Vrana O, Kleinwachter V (1986) Studia Biophysica 114: 199
Eastman A (1987) Biochem. Pharmacol. 36: 4177
Kuroda R, Neidle S, Ismail IM, Sadler PJ (1983) Inorg. Chem. 22: 3620
Rosenberg B, van Camp L, Trosko JE, Mansour VH (1969) Nature 222: 385
Razaka H, Salles B, Villani G, Johnson NP (1986) Chem.-Biol. Interact. 60: 207
Das Sarma B, Daley SK, Elespuru RK (1983) Chem.-Biol. Interact. 46: 219
Mong S, Huang CH, Prestayko AW, Crooke ST (1980) Cancer Res. 40: 3313
Mong S, Eubanks DC, Prestayko AW, Crooke ST (1982) Biochem. 21: 3174
Vollano JF, Blatter EE, Dabrowiak JC (1984) J. Am. Chem. Soc. 106: 2732
Salles B, Defais M (1984) Mutation Res. 131: 53
Salles B, Germanier M, Defais M (1987) Mutation Res. 183: 213
Neidle S, Waring MJ (eds) (1983) Molecular aspects of anticancer drug action, Chemie, Wein- heim.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Johnson, N.P. et al. (1989). Metal Antitumor Compounds: The Mechanism of Action of Platinum Complexes. In: Baulieu, E., et al. Ruthenium and Other Non-Platinum Metal Complexes in Cancer Chemotherapy. Progress in Clinical Biochemistry and Medicine, vol 10. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74760-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-74760-1_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74762-5
Online ISBN: 978-3-642-74760-1
eBook Packages: Springer Book Archive